Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related FB
Chegg CEO: 'In Essence, We Re-IPOed The Company'
Damodaran: Watch Price Divergences In The 'Aging' Tech Sector
A new suicide prevention (Investor's Business Daily)
Related BMY
Bristol Myers Reports Data Supporting Clinical Development Of BMS-955176
Bristol-Myers Squibb Launches Phase III Trial Of HIV Drug
Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More (Seeking Alpha)

Analysts at BMO Capital upgraded Facebook (NASDAQ: FB) from “underperform” to “outperform.” Facebook's stock closed at $25.91 on Friday. Facebook had $10.45 billion in total cash for the latest quarter.

Atlantic Equities upgraded Bristol-Myers Squibb Company (NYSE: BMY) from “underweight” to “neutral.” Bristol-Myers' shares closed at $32.46 on Friday. Bristol-Myers' PEG ratio is 6.25.

Analysts at Needham upgraded PMFG (NASDAQ: PMFG) from “hold” to “buy.” PMFG's shares closed at $8.60 on Friday. PMFG's trailing-twelve-month revenue is $139.21 million.

Latest Ratings for FB

DateFirmActionFromTo
Jan 2015Stifel NicolausMaintainsBuy
Jan 2015CRT CapitalMaintainsBuy
Jan 2015JefferiesMaintainsBuy

View More Analyst Ratings for FB
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (BMY + FB)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→